课题基金 / 基金详情

CEL-HYB2杂合基因变异在早发型慢性胰腺炎中的遗传致病机制研究

批准号:
82070661
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
邹文斌
学科分类:
胰腺外分泌功能异常与胰腺炎
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
邹文斌

项目摘要

结项摘要

邹文斌的其他基金

相似基金

相关文献

中文摘要
慢性胰腺炎(chronic pancreatitis, CP)是一种与遗传因素密切相关的胰腺炎症性疾病,其机制不清,病因复杂,临床表现为腹痛、糖尿病和脂肪泻等。CEL基因编码一种胰腺外分泌酶-羧基酯脂肪酶,可与其下游假基因同源重组成CEL-HYB变异。欧洲人群主要为CEL-HYB1型,体外实验证实该变异可诱导细胞自噬发生;申请者前期发现亚洲CP主要携带CEL-HYB2型,且在早发型CP中高发,提示中西方差异。本课题拟通过扩大样本量,采用自主设计检测方法和生信分析,进一步明确CEL-HYB2在我国早发型CP中的作用、分子分型及其影响因素。基于前期体外功能实验,发现CEL-HYB2可发生无义介导mRNA降解,本研究拟进一步阐明该变异导致的蛋白水平变化、体外效应及具体致病机制;结合外源因素刺激,分别构建两种携带CEL-HYB的人源化基因小鼠,为CP基因和药物治疗提供新的依据和新的临床前动物模型。
英文摘要
Chronic pancreatitis (CP) is a genetic-related inflammatory disease of the pancreas with complex etiology and unclear mechanism. The clinical features of CP are characterized by abdominal pain, diabetes mellitus and steatorrhea. The CEL-HYB, a hybrid allele generated by homologous recombination between CEL (encoding carboxyl ester lipase) and its downstream pseudogene, including CEL-HYB1 and CEL-HYB2. The CEL-HYB1 was mainly found in European populations, which was previously confirmed to be induced autophagy in cell experiments. However, we found the CEL-HYB2 was predominated in the Asia cohort and highly carried in early-onset CP patients, which indicated the genetic differences between the West and East. We aim to screen for CEL-HYB2 in an extended cohort of Chinese early-onset CP patients by self-designed detection methods and bioinformatic analysis, in order to determine the exact role of CEL-HYB2 in CP and evaluate the molecular sub-types and its associated factors. Our previous in vitro functional studies suggested CEL-HYB2 was subject to nonsense-mediated mRNA decay. Based on previous findings, this study aims to further explore the protein level, enzyme activity, cellular clearance and pathogenic mechanisms of CEL-HYB2. We have been establishing the humanized CEL-HYB1 and CEL-HYB2 mice combining environmental stimulus (caerulein, alcohol and high-fat diet), in order to provide novel animal models and theoretical references for the preclinical drug development and gene therapy of CP.
慢性胰腺炎(chronic pancreatitis, CP)是一种与遗传因素密切相关的胰腺炎症性疾病,其机制不清,病因复杂,临床表现为腹痛、糖尿病和脂肪泻等。CEL基因编码一种胰腺外分泌酶-羧基酯脂肪酶,可与其下游假基因同源重组成CEL-HYB变异。本课题的主要目的是研究CEL-HYB在CP中的致病作用和潜在机制。前期研究表明,CEL-HYB变异能够增加CP的患病风险,但存在不同亚型和种族特异性,且其作用机制不清。本课题首先发现与欧洲人群中的CEL-HYB1变异不同,CEL-HYB2仍然是中国人群中主要的分子亚型,且在早发型ICP患者中显著富集。细胞实验证明,CEL-HYB1与CEL-HYB2均能引起编码CEL蛋白分泌受阻和胞内滞留。相比于野生型CEL或CEL-HYB2,CEL-HYB1蛋白在工具细胞中的表达引起内质网应激标志物的显著升高。其次,我们成功构建了表达人源CEL-HYB1和CEL的遗传小鼠模型。在自然生长下,人源化CEL-HYB1小鼠出现了时间依赖性的局灶性胰腺损伤,包括腺泡萎缩和空泡化、炎症浸润和纤维化,伴随细胞凋亡标志物的升高和嗜酸性包涵体的形成。接下来,结合雨蛙素诱导,研究发现CEL-HYB1变异通过错误折叠依赖途径促进胰腺腺泡细胞内质网应激,自噬受损在晚期胰腺损伤中发挥了重要作用。因此,CEL-HYB1变异促进了雨蛙素诱导胰腺炎的严重程度,提示该变异可能增加胰腺炎易感性。最后,由于CEL-HYB变异会引起末端VNTR长度显著缩短,我们在中国人群中检测了CEL末端VNTR长度与ICP、ACP的相关性,发现CEL基因末端VNTR的长度与ACP无显著关联,而以纯合形式存在的较短CEL基因VNTR序列可能会增加ICP的易感性。该研究丰富了CP遗传致病机制理论,为CP精准防治提供新的依据和临床前动物模型。
SPINK1基因内含子突变的鉴定及其在慢性胰腺炎中的致病机制研究
国内基金
海外基金